跳至主要内容
临床试验/CTRI/2019/10/021486
CTRI/2019/10/021486尚未招募2 期

A prospective study to see the feasibility toxicity and efficacy of twice weekly interdigited intracavitary brachytherapy in patients of carcinoma cervix stage II B Undergoing concurrent chemoradiation

RADIOTHERAPY DEPARTMENT SSKM HOSPITA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Age: 18 to 65 years.
  • 2)Histology proven squamous cell carcinoma of cervix.
  • 3)Patients with stage IIB
  • 4)ECOG performance status 0 to 2
  • 5)No previous history of treatment of cancer.
  • 6)Creatinine clearance more than or equal to 60 ml/min
  • 7)Patients must sign a study specific informed consent prior to study entry.

排除标准

  • 1)Evidence of distant metastases by clinical or radiological examination.
  • 2)Previous history of treatment of pelvic malignancies.
  • 3)Previous history of pelvic irradiation.
  • 4)Other primary malignancy.
  • 5)Significant co-morbidities that would not allow or would require modification of treatment of the study protocol.

研究者

发起方
RADIOTHERAPY DEPARTMENT SSKM HOSPITA

相似试验